DE1450454U - - Google Patents

Info

Publication number
DE1450454U
DE1450454U DENDAT1450454D DE1450454DU DE1450454U DE 1450454 U DE1450454 U DE 1450454U DE NDAT1450454 D DENDAT1450454 D DE NDAT1450454D DE 1450454D U DE1450454D U DE 1450454DU DE 1450454 U DE1450454 U DE 1450454U
Authority
DE
Germany
Prior art keywords
dte
dea
den
ç3tlete
xnspruoh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1450454D
Other languages
German (de)
English (en)
Publication of DE1450454U publication Critical patent/DE1450454U/de
Active legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DENDAT1450454D Active DE1450454U (enExample)

Publications (1)

Publication Number Publication Date
DE1450454U true DE1450454U (enExample)

Family

ID=758234

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1450454D Active DE1450454U (enExample)

Country Status (1)

Country Link
DE (1) DE1450454U (enExample)

Similar Documents

Publication Publication Date Title
US6919370B2 (en) Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
Sessink et al. Evaluation of the PhaSeal hazardous drug containment system
US20190145741A1 (en) Tactical wall panel, assembly and methods of deployment and use
SK423889A3 (en) Pharmaceutical mixture for the prevention of veneral diseases
EP4065922B1 (de) Modulare schutzbekleidungseinheit sowie deren verwendung
JP2021001189A5 (enExample)
Tartaglione Treatment of nontuberculous mycobacterial infections: role of clarithromycin and azithromycin
Reynes et al. TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals
Kanj et al. The battle against fungi: lessons in antifungal stewardship from COVID 19 times
Dass et al. Paracetamol and conventional antimalarial drugs induced hepatotoxicity and its protection by methionine in rats
Schneider et al. Management of HCV-associated liver cirrhosis
Gaddoni et al. Contact dermatitis among decorators and enamellers in hand-made ceramic decorations.
DE1517474U (enExample)
Murskyj Disseminated histoplasmosis after vedolizumab treatment for ulcerative colitis
DE1502554U (enExample)
Mccorquodale et al. Helicopter immobilization of elk in southcentral Washington
US3663693A (en) Antimalarial compositions and methods of their use
ES2304163T3 (es) Solucion inyectable esteril estable, lista para usar, de 9-((1,3-dihidroxipropan-2-iloxi)metil)-2-amina-1h-purin-6(9h)-ona; sistema cerrado para envasar solucion; procedim. eliminar residuos alcalinos cristales de 9-((1,3-dihidroxipropan-2-iloxi)metil)-2-amina-1h-purin-6(9h)-ona.
DE1487257U (enExample)
CN211584289U (zh) 一种新型便于艾滋病人使用的药盒
Kononenko et al. Experimental rationale of selection of the hypoglicemic dose of ginger dry extract on normoglycemic rats
林慧 Evaluation of Irinotecan and Trifluridine/Tipiracil as Fourth-line Treatments After Third-line Nivolumab for Advanced Gastric Cancer
PL246350B1 (pl) Pochodne kwasu (2,4-diokso-1,3-tiazolidyn-3-ylo)octowego, sposób ich wytwarzania oraz ich zastosowanie medyczne
DE1532219U (enExample)
DE1416562U (enExample)